Hologic Inc (NASDAQ: HOLX) has reported E.P.S. of $0.37 for its fourth fiscal quarter (ending September 30) versus $0.47 for the same period a year ago — a decline of -21%. Relative to the consensus estimate of $0.84, this was a shortfall of $-0.47. For the latest four quarters through September 30, E.P.S. were $1.85 compared to $5.18 a year ago — a decline of -64%.
Recent Price Action
Hologic Inc (NASDAQ: HOLX) stock declined by -1.6% on 11/9/23. The shares closed at $67.20. The stock has been weak relative to the market over the last nine months but has risen 0.8% during the last week.
Current PriceTarget Research Rating
With future capital returns forecasted to be above the cost of capital, HOLX is expected to continue to be a major Value Builder.
Hologic has a current Value Trend Rating of D (Negative). The Value Trend Rating reflects consistent signals from PTR’s two proprietary measures of a stock’s attractiveness. Hologic has a neutral Power Rating of 46 and a slightly negative Appreciation Score of 32, with the Negative Value Trend Rating the result.
Rating Review
In light of this new information we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment